NASDAQ:INBS Intelligent Bio Solutions (INBS) Stock Price, News & Analysis $1.47 -0.07 (-4.55%) As of 09:50 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsNews and TrendsSEC Filings About Intelligent Bio Solutions Stock (NASDAQ:INBS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get INBS alerts:Sign Up Key Stats Today's Range$1.45▼$1.4650-Day Range$1.44▼$2.2952-Week Range$1.35▼$24.90Volume5,620 shsAverage Volume266,745 shsMarket Capitalization$4.88 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview Intelligent Bio Solutions Inc. is a medical technology company focused on non-invasive testing and diagnostic solutions. Its flagship offering is the Intelligent Fingerprinting Drug Screening System, which analyzes trace sweat collected from a person’s fingertips to screen for drugs. The system combines a portable reader with single-use fingerprint test cartridges. Its compact format is designed for use in settings such as workplaces, law enforcement, drug treatment and rehabilitation programs, and other organizations that conduct screening. The company adopted its current name after acquiring UK-based Intelligent Fingerprinting in 2023. Its fingerprint testing technology is developed and commercialized through operations serving customers in multiple markets.AI Generated. May Contain Errors. Read More Intelligent Bio Solutions Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks25th Percentile Overall ScoreINBS MarketRank™: 1.22526113249 of 5 starsIntelligent Bio Solutions scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingReduce Consensus RatingIntelligent Bio Solutions has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageIntelligent Bio Solutions has only been the subject of 1 research reports in the past 90 days.Read more about Intelligent Bio Solutions' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($5.18) to ($4.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Intelligent Bio Solutions is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Intelligent Bio Solutions is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIntelligent Bio Solutions has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.97% of the float of Intelligent Bio Solutions has been sold short.Short Interest Ratio / Days to CoverIntelligent Bio Solutions has a short interest ratio ("days to cover") of 3.08, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Intelligent Bio Solutions has recently decreased by 30.26%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIntelligent Bio Solutions does not currently pay a dividend.Dividend GrowthIntelligent Bio Solutions does not have a long track record of dividend growth. News and Social Media1.5 / 5News SentimentN/A News SentimentIntelligent Bio Solutions has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.Percentage Held by Insiders2.76% of the stock of Intelligent Bio Solutions is held by insiders.Percentage Held by Institutions32.97% of the stock of Intelligent Bio Solutions is held by institutions.Read more about Intelligent Bio Solutions' insider trading history. Receive INBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INBS Stock News HeadlinesIntelligent Bio Solutions (NASDAQ:INBS) versus DexCom (NASDAQ:DXCM) Head to Head AnalysisNovember 13, 2026 | americanbankingnews.comIntelligent Bio Solutions Reports Record Fiscal First Quarter 2027 Revenue of $1.39 Million, Marking Sixth Consecutive Quarter of Year-Over-Year GrowthNovember 10, 2026 | globenewswire.comDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.November 20 at 1:00 AM | Weiss Ratings (Ad)Intelligent Bio Solutions (INBS) Set to Announce Earnings on WednesdayNovember 10, 2026 | americanbankingnews.comIntelligent Bio Solutions to Present at the Webull Biotech Webinar on November 12November 4, 2026 | globenewswire.comIntelligent Bio Solutions Inc. (INBS) Discusses FDA 510(k) Submission and Progress of Intelligent Fingerprinting Drug Screening System TranscriptSeptember 24, 2026 | seekingalpha.comIntelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ETSeptember 10, 2026 | globenewswire.comIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market ClearanceSeptember 9, 2026 | finanznachrichten.deSee More Headlines INBS Stock Analysis - Frequently Asked Questions How have INBS shares performed this year? Intelligent Bio Solutions' stock was trading at $9.53 on January 1st, 2026. Since then, INBS stock has decreased by 84.2% and is now trading at $1.51. How were Intelligent Bio Solutions' earnings last quarter? Intelligent Bio Solutions Inc. (NASDAQ:INBS) posted its earnings results on Tuesday, November, 10th. The company reported ($0.86) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.31) by $0.45. The company had revenue of $1.39 million for the quarter, compared to analysts' expectations of $1.40 million. Intelligent Bio Solutions had a negative trailing twelve-month return on equity of 150.00% and a negative net margin of 269.28%. When did Intelligent Bio Solutions' stock split? Shares of Intelligent Bio Solutions reverse split on the morning of Monday, January 29th 2024.The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. When did Intelligent Bio Solutions IPO? Intelligent Bio Solutions (INBS) raised $22 million in an IPO on Wednesday, December 23rd 2020. The company issued 1,270,589 shares at a price of $16.00-$18.00 per share. How do I buy shares of Intelligent Bio Solutions? Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Intelligent Bio Solutions own? Based on aggregate information from My MarketBeat watchlists, some other companies that Intelligent Bio Solutions investors own include NVIDIA (NVDA), Quantum Computing (QUBT), SNDL (SNDL), Energy Fuels (UUUU), Energy Transfer (ET), Salesforce (CRM) and Aeva Technologies (AEVA). Company Calendar Last Earnings11/10/2026Today11/20/2026Fiscal Year End6/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (4d) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 As of 4 days ago, INBS's financial health entered the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:INBS Previous SymbolNASDAQ:GBS CIK1725430 Webwww.ibs.inc Phone(646) 790-5756FaxN/AEmployees60Year FoundedN/AProfitability EPS (Trailing Twelve Months)($6.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.43 million Net Margins-269.28% Pretax Margin-270.06% Return on Equity-150.00% Return on Assets-83.38% Debt Debt-to-Equity RatioN/A Current Ratio1.98 Quick Ratio1.87 Sales & Book Value Annual Sales$4.22 million Price / Sales1.15 Cash FlowN/A Price / Cash FlowN/A Book Value$2.22 per share Price / Book0.66Miscellaneous Outstanding Shares3,320,000Free Float3,225,000Market Cap$4.87 million OptionableNot Optionable Beta4.48 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:INBS) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredI'm handing you this one freeDylan has tracked down the company behind what he calls the StarChip. It's already inside more than 10,000 Sta...Behind the Markets | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intelligent Bio Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intelligent Bio Solutions With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.